Overall survival in patients. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy3

Cell Line, Tumor Lymph Nodes Neoplastic Cells, Circulating

Diseases76

Neoplasm Recurrence, Local Breast Neoplasms Lung Neoplasms Neoplasm Metastasis Adenocarcinoma Disease Progression Lymphatic Metastasis Carcinoma, Non-Small-Cell Lung Liver Neoplasms Colorectal Neoplasms Recurrence Brain Neoplasms Carcinoma, Squamous Cell Ovarian Neoplasms Carcinoma Multiple Myeloma Stomach Neoplasms Carcinoma, Hepatocellular Leukemia, Myeloid, Acute Lymphoma, Large B-Cell, Diffuse Melanoma Neoplasm Invasiveness Pancreatic Neoplasms Bone Neoplasms Head and Neck Neoplasms Glioblastoma Kidney Neoplasms Esophageal Neoplasms Hodgkin Disease Lymphoma, Non-Hodgkin Sarcoma Carcinoma, Renal Cell Lymphoma, Follicular Nasopharyngeal Neoplasms Rectal Neoplasms Skin Neoplasms Central Nervous System Neoplasms Prostatic Neoplasms Neoplasms, Glandular and Epithelial Peritoneal Neoplasms Leukemia, Lymphocytic, Chronic, B-Cell Precursor Cell Lymphoblastic Leukemia-Lymphoma Glioma Neoplasm, Residual Soft Tissue Neoplasms Graft vs Host Disease Myelodysplastic Syndromes Osteosarcoma Neutropenia Urinary Bladder Neoplasms Neoplasms Oropharyngeal Neoplasms Cystadenocarcinoma, Serous Neoplastic Cells, Circulating Lymphoma, B-Cell Colonic Neoplasms Carcinoma, Ductal, Breast Small Cell Lung Carcinoma Neoplasms, Second Primary Carcinoma, Transitional Cell Leukemia, Myeloid Endometrial Neoplasms Cholangiocarcinoma Laryngeal Neoplasms Postoperative Complications Biliary Tract Neoplasms Lymphoma, Mantle-Cell Hematologic Diseases Rhabdomyosarcoma Carcinoma, Small Cell Carcinoma, Pancreatic Ductal Hypopharyngeal Neoplasms Pleural Neoplasms Bile Duct Neoplasms Hematologic Neoplasms Lymphoma

Chemicals and Drugs71

Tumor Markers, Biological Antineoplastic Agents Fluorouracil Cisplatin Vincristine Cyclophosphamide Doxorubicin Deoxycytidine Prednisone Organoplatinum Compounds Antibodies, Monoclonal, Humanized Etoposide Leucovorin Taxoids Dacarbazine Antimetabolites, Antineoplastic Carboplatin Paclitaxel Vinblastine Cytarabine Methotrexate Camptothecin Antibodies, Monoclonal Antibodies, Monoclonal, Murine-Derived Antineoplastic Agents, Alkylating Receptor, erbB-2 Melphalan Bleomycin Procarbazine Thalidomide Epirubicin Antineoplastic Agents, Hormonal Anthracyclines Platinum Compounds Niacinamide Ifosfamide Receptors, Estrogen Quinazolines Phenylurea Compounds Receptors, Progesterone Mitoxantrone Neoplasm Proteins Benzenesulfonates Ki-67 Antigen Tamoxifen Protein Kinase Inhibitors Receptor, Epidermal Growth Factor Antineoplastic Agents, Phytogenic Tumor Suppressor Protein p53 Mechlorethamine Lomustine Vidarabine Angiogenesis Inhibitors Tegafur Carmustine Daunorubicin RNA, Messenger Proto-Oncogene Proteins Interferon-alpha Boronic Acids Pyrimidines Pyrazines Oxonic Acid Dexamethasone Antibiotics, Antineoplastic Idarubicin Platinum Benzamides Chlorambucil Myeloablative Agonists Pyrroles

Analytical, Diagnostic and Therapeutic Techniques and Equipment86

Survival Rate Disease-Free Survival Survival Analysis Treatment Outcome Prognosis Antineoplastic Combined Chemotherapy Protocols Kaplan-Meier Estimate Neoplasm Staging Retrospective Studies Combined Modality Therapy Follow-Up Studies Proportional Hazards Models Chemotherapy, Adjuvant Multivariate Analysis Drug Administration Schedule Remission Induction Immunohistochemistry Radiotherapy, Adjuvant Neoadjuvant Therapy Prospective Studies Salvage Therapy Chemoradiotherapy Predictive Value of Tests Transplantation, Autologous Cohort Studies Risk Factors Radiotherapy Dosage Neoplasm Grading Hematopoietic Stem Cell Transplantation Clinical Trials, Phase III as Topic Transplantation, Homologous Radiotherapy Randomized Controlled Trials as Topic Risk Assessment Dose Fractionation Tissue Array Analysis Induction Chemotherapy Treatment Failure Life Tables Infusions, Intravenous Clinical Trials as Topic Actuarial Analysis Lymph Node Excision Tumor Burden Transplantation Conditioning Clinical Trials, Phase II as Topic Hepatectomy Chemoradiotherapy, Adjuvant Reverse Transcriptase Polymerase Chain Reaction Registries Gene Expression Profiling Stem Cell Transplantation Immunoenzyme Techniques Cranial Irradiation SEER Program Chi-Square Distribution Palliative Care Analysis of Variance Probability Karnofsky Performance Status Chemoembolization, Therapeutic Radiosurgery Brachytherapy Esophagectomy Cystectomy In Situ Hybridization, Fluorescence Patient Selection Radiotherapy, Conformal Nomograms Bone Marrow Transplantation Maintenance Chemotherapy Gastrectomy Multicenter Studies as Topic Peripheral Blood Stem Cell Transplantation Positron-Emission Tomography Incidence Radiotherapy, Intensity-Modulated Mastectomy Cytogenetic Analysis Preoperative Care Feasibility Studies Statistics, Nonparametric Immunotherapy Liver Transplantation Cause of Death Endpoint Determination

Phenomena and Processes13

Cell Survival Time Factors Graft Survival Gene Expression Regulation, Neoplastic Drug Resistance, Neoplasm Apoptosis Mutation Dose-Response Relationship, Drug Signal Transduction Cell Proliferation Chi-Square Distribution Probability Nomograms

Disciplines and Occupations1

Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena2

Survival Quality of Life

Humanities1

Quality of Life

Information Science8

Survival Rate Life Tables Registries SEER Program Radiotherapy, Conformal Incidence Radiotherapy, Intensity-Modulated Cause of Death

Named Groups1

Health Care37

Survival Rate Disease-Free Survival Survival Analysis Treatment Outcome Kaplan-Meier Estimate Retrospective Studies Follow-Up Studies Proportional Hazards Models Multivariate Analysis Prospective Studies Predictive Value of Tests Cohort Studies Risk Factors Clinical Trials, Phase III as Topic Randomized Controlled Trials as Topic Risk Assessment Age Factors Treatment Failure Life Tables Clinical Trials as Topic Actuarial Analysis Clinical Trials, Phase II as Topic Registries SEER Program Chi-Square Distribution Palliative Care Analysis of Variance Probability Karnofsky Performance Status Patient Selection Nomograms Multicenter Studies as Topic Incidence Preoperative Care Feasibility Studies Statistics, Nonparametric Cause of Death

Geographicals2

United States Japan

Anatomy Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Health Care

Survival Rate Disease-Free Survival Survival Analysis Treatment Outcome Prognosis Cell Survival Antineoplastic Combined Chemotherapy Protocols Kaplan-Meier Estimate Neoplasm Staging Retrospective Studies Combined Modality Therapy Survival Neoplasm Recurrence, Local Follow-Up Studies Proportional Hazards Models Chemotherapy, Adjuvant Tumor Markers, Biological Antineoplastic Agents Time Factors Breast Neoplasms Fluorouracil Graft Survival Lung Neoplasms Multivariate Analysis Neoplasm Metastasis Cisplatin Adenocarcinoma Vincristine Cyclophosphamide Doxorubicin Disease Progression Lymphatic Metastasis Drug Administration Schedule Remission Induction Immunohistochemistry Radiotherapy, Adjuvant Deoxycytidine Carcinoma, Non-Small-Cell Lung Liver Neoplasms Colorectal Neoplasms Prednisone Recurrence Brain Neoplasms Carcinoma, Squamous Cell Neoadjuvant Therapy Prospective Studies Salvage Therapy Organoplatinum Compounds Ovarian Neoplasms Antibodies, Monoclonal, Humanized Etoposide Chemoradiotherapy Predictive Value of Tests Leucovorin Taxoids Transplantation, Autologous Cohort Studies Dacarbazine Risk Factors Antimetabolites, Antineoplastic Carcinoma Multiple Myeloma Carboplatin Radiotherapy Dosage Paclitaxel Gene Expression Regulation, Neoplastic Vinblastine Stomach Neoplasms Carcinoma, Hepatocellular Neoplasm Grading Leukemia, Myeloid, Acute Hematopoietic Stem Cell Transplantation Clinical Trials, Phase III as Topic Lymphoma, Large B-Cell, Diffuse Transplantation, Homologous Melanoma Neoplasm Invasiveness Cytarabine Pancreatic Neoplasms Radiotherapy Randomized Controlled Trials as Topic Methotrexate Bone Neoplasms Camptothecin Head and Neck Neoplasms Antibodies, Monoclonal Glioblastoma Risk Assessment Dose Fractionation Age Factors Antibodies, Monoclonal, Murine-Derived Drug Resistance, Neoplasm Kidney Neoplasms Esophageal Neoplasms Cell Line, Tumor Hodgkin Disease Tissue Array Analysis Lymphoma, Non-Hodgkin Antineoplastic Agents, Alkylating Receptor, erbB-2

No FAQ available that match "overall survival in patients"